Aier Eye Hospital Partners with Chunyu Doctor to Accelerate Mobile Healthcare Strategy

On August 29, Aier Eye Hospital Group issued a public announcement stating: To seize new opportunities in the mobile internet era, the Company, based on the specific characteristics of the healthcare services industry, leverages the unique advantages of its nationwide tiered chain hospital network and relies on the robust strength of its extensive medical team. By integrating and utilizing various social medical and technical resources, the Company has formulated and implemented the “Aier Eye Hospital Mobile Healthcare Development Plan.” The objective is to build an all-encompassing “Eye Health Assurance System” that spans online and offline channels, integrates medical treatment with prevention, and coordinates care within and outside hospitals, thereby providing high-quality, lifelong eye health management for China’s 1.4 billion people. Meanwhile, in terms of industrial development, the Company will comprehensively innovate its business and service models for the new era, aiming to take the lead in establishing a mobile healthcare system with advanced business models and clear profitability patterns, thus cultivating an “Eye Health Ecosystem.”

Aier Eye Hospital Mobile Healthcare System Architecture Diagram:

Based on this strategic vision, Aier Eye Hospital plans to advance and implement the initiative across the following three levels:

1. Build a unified IT infrastructure based on “cloud architecture” to achieve efficient, low-cost organic integration and systematic consolidation across information, business operations, technology, services, and management, thereby providing robust IT support for mobile healthcare; meanwhile, centering on “services,” upgrade and reengineer business processes to break through geographical and physical limitations in service coverage, enable 24/7 availability in service hours, and meet the dynamic needs of eye health in service content, thus fostering deep connectivity and interaction between hospitals and clients as well as between doctors and patients, comprehensively enhancing the clinical technical capabilities of hospitals at all levels and improving the service experience for clients nationwide.

2. Continuously invest in the development of intelligent ophthalmic equipment, and leverage technologies such as telemedicine and mobile internet to integrate multi-tier offline medical networks with online cloud service platforms. This will create an online-offline synergistic closed loop with expanding scope and deepening content, thereby significantly and efficiently broadening service offerings, target populations, and market reach. The goal is to establish a new O+O (Online-to-Offline) eye health service model that integrates channel management, consultation, examination, treatment, rehabilitation, healthcare, and education.

3. Actively deploy in fields such as intelligent image recognition, iris recognition, big data, artificial intelligence, smart healthcare, and the Internet of Things; incubate high-quality projects that combine technological advancement with market feasibility; and cultivate an eye health service ecosystem characterized by horizontal breadth, vertical depth, and dense synergy. This will comprehensively accelerate the development of China’s eye health sector, enable high-level competition and collaboration with the international ophthalmology and vision science community, and continuously provide users and patients with diversified and innovative eye health services.

In accordance with the overall deployment of its mobile health strategy, Aier Eye Hospital has actively laid out its plans and implemented them in stages. On one hand, it is accelerating the upgrading and transformation of medical informatization to build advanced infrastructure for mobile health services. On the other hand, it is systematically establishing a grassroots service network, researching and investing in leading domestic and international mobile health projects, and integrating various social resources.

1. Accelerate the construction of next-generation healthcare information systems to enhance clinical technical capabilities and service experience through preliminary efforts

Aier Eye Hospital has essentially achieved comprehensive coverage of offline Hospital Information Systems (HIS) and, in accordance with the diverse operational requirements of its hospitals, has deployed specialized medical business support systems—including Electronic Medical Records (EMR), Picture Archiving and Communication Systems (PACS), and Laboratory Information Systems (LIS)—to help enhance clinical technical capabilities and improve patient service experiences.

Next, while continuously meeting the informatization needs of newly opened hospitals, the Company will form strategic partnerships with leading domestic and international vendors to independently develop a new-generation Hospital Information System (AHIS). Leveraging a “Cloud × Service” mechanism, it will pioneer the construction of an IT service system that is service-centric, built on cloud architecture, and covers all institutions within the Aier system (including hospitals, clinics, etc.). Initially, this will encompass basic cloud-based HIS functionalities focused on medical and nursing services; subsequently, the Company will continue to research and develop other medical business support systems with independent intellectual property rights, such as EMR, PACS, and LIS.

The new-generation information system will adhere to the core mission of “continuously developing and meeting patient needs through a team-based medical model integrating clinical care and marketing.” With “safety, quality, management, and service” as its construction objectives, it will highlight “patient services, patient experience, and patient perception” as its distinguishing features. This initiative will make informatization a robust safeguard for the company’s efficient, standardized, and scientific operational management in the new era, while also laying a solid implementation foundation for the in-depth advancement of its mobile health strategy.

2. Invest in Hunan Jishi Hulian Technology Co., Ltd. to extend and expand the grassroots entry point for mobile healthcare

To innovate eye health service models, Aier Eye Hospital invested RMB 10 million to jointly invest in Hunan Jishi Internet Technology Co., Ltd. (hereinafter referred to as “Jishi Internet”) with Nanjing Aier Anxing Medical Industry Investment Center. The registered capital is RMB 100 million, and the company holds a 10% stake.

Jishi Interconnect centers on eye health services, creating an integrated online-to-offline (O2O) eye health service model through the synergy of its online cloud service platform and offline “Eye Care e-Stations.” On one hand, it extensively establishes offline eye health experience stores in urban communities, county-level towns, and villages through various models such as partnerships, self-operated outlets, and franchising. These stores emphasize a functional positioning of “professionalism, convenience, and efficiency,” aiming to deliver basic services within communities, refer complex cases to hospitals, and facilitate post-treatment rehabilitation back in the community. On the other hand, it has built an online cloud service platform specialized in ophthalmology, integrating services such as online consultations, self-assessment tools, health education, remote diagnosis and treatment, and an online store. This platform drives greater patient traffic, enhances user perception through offline service experiences, and improves service quality and efficiency through data collection and analysis.

After nearly six months of development, Jishi Interconnect has established multiple Community Eye Care e-Stations in cities such as Changsha, Tianjin, and Chengdu, actively exploring pathways for community-based eye health services. Meanwhile, the screening system and business operation system independently developed by Jishi Interconnect have been deployed in actual eye health service operations, securing two software copyrights. The research and development of online products, including its APP, telemedicine platform, and “Sky Eye” system, are proceeding in an orderly manner.

By investing in Jishi Hulian, Aier Eye Hospital will further expand its reach at the grassroots level, creating a widely covered and convenient offline eye health service network and a high-quality, high-efficiency professional online service platform. This will achieve seamless integration between online and offline services, provide the general public with high-quality and convenient end-to-end services, form a closed-loop eye health service system, and establish this model as a benchmark in China’s mobile healthcare sector.

3. Strategically incubate new mobile health technologies and resources to build an eye health service ecosystem

Aier Eye Hospital is actively promoting the application of artificial intelligence in the healthcare sector, while also establishing industrial layouts in related fields such as virtual reality, smart wearables, and intelligent healthcare. Through multi-faceted strategic collaborations, including investments and joint development initiatives, the hospital integrates various new technologies, business formats, and models within the mobile health domain to significantly enrich its application services. Currently, the following key initiatives are being advanced and implemented:

(1) Investment in Hangzhou Jingzhijing Technology Co., Ltd. (hereinafter referred to as “Jingzhijing Tech”)

Given the broad market prospects for wearable ophthalmic devices, the Company invested RMB 781,250 to increase its capital contribution in Hangzhou Jingzhijing Technology Co., Ltd. Following the capital increase, the registered capital amounted to RMB 1 million, with the Company holding a 10% equity stake.

Mirror Mirror Technology is a high-tech enterprise dedicated to the research and development of ophthalmic wearable devices, with its core team possessing years of experience in ophthalmic product development. Through collaborative R&D with optometry experts from the Aier Eye Hospital Group, Mirror Mirror Technology has launched “Cloud Clip,” an innovative product in the global ophthalmology field. This device comprehensively monitors users’ eye usage behaviors and intervenes against various unscientific visual habits, demonstrating strong user stickiness and significant market potential.

The product won first place in the finals of the inaugural China "Internet+" College Student Innovation and Entrepreneurship Competition, hosted by the Ministry of Education of China in October 2015. At the International Forum on Innovative Development of Visual Health held in July 2016, 13 leading ophthalmology experts from China and abroad jointly validated and announced that Yunjia achieves a monitoring accuracy of up to 97% in myopia control, potentially representing a new and effective tool for the clinical prevention and management of myopia. In view of the complementary strengths between the Company and Jingzhijing Technology in product R&D, ophthalmic expertise, and market channels, Aier Eye Hospital will engage in deep strategic cooperation with them to jointly develop ophthalmic-related products, actively promote product commercialization, and explore new business models.

(2) Investment in Taiwan Jinhong Technology Co., Ltd.

To keep pace with international technological advancements in telemedicine, Aier Eye Hospital’s wholly-owned subsidiary, Aier Eye Hospital International (Hong Kong) Co., Ltd., invested an amount equivalent to RMB 10 million in Hong Kong dollars or New Taiwan dollars to increase its capital stake in JinHong Technology. Following the capital injection, the company holds a 10% equity interest.

Jinhong Technology is a high-tech enterprise specializing in the production of innovative digital medical imaging equipment. Its products are primarily applied in convenient examinations (screening) and telemedicine. The company has successively received the Taiwan Biomedical and Agricultural Industry Award, multiple business innovation awards from the Ministry of Economic Affairs of Taiwan, and the Asian Incubation Association’s Torch Enterprise Internationalization Award. Its products and services have gained extensive entry into mainstream international markets, including the United States, Japan, and Europe.

Jinhong Technology’s strategic shareholders include Welch Allyn, a globally renowned medical device company based in the United States. By increasing its equity investment in Jinhong Technology, Aier Eye Hospital can closely monitor new developments in the international telemedicine sector and secure a first-mover advantage in the development of China’s domestic telemedicine market. Jinhong Technology is currently in a phase of rapid growth and plans to list on the Taiwan stock exchange in the future, allowing the company to share in the benefits of its future rapid business expansion and development.

(3) Development of the “Intelligent Ophthalmic Image Reading Management System”

Aier Eye Hospital has entered into a cooperation agreement with Taiwan’s Jinhong Technology and National Chiao Tung University to develop a remote intelligent image reading management system leveraging internationally mainstream convolutional neural network (CNN) algorithms. This system will provide fully automated AI-based image interpretation, delivering objective, quantitative, and real-time analysis of patients’ fundus images. It addresses key challenges such as high physician workload and variability in diagnostic expertise, playing a significant role in expanding the scope of ophthalmic screening and reducing the time required for definitive diagnosis.

(4) Development of the “Aier AR Glasses Virtual Try-On System”

To further enhance user experience, Aier Eye Hospital began collaborating in May 2016 with the Hunan Intelligent Interaction Engineering Technology Research Center and a professional team from the National University of Defense Technology to jointly develop the “Aier AR Glasses Virtual Try-On System.” This system provides a comprehensive suite of functionalities for experiencing and selling eyewear products, ranging from 3D modeling of glasses and front-end virtual try-ons for users to back-end data maintenance and try-on statistics. It enables customers to select eyewear products in a batched, customized, and convenient manner across various scenarios. This technology will significantly improve the user experience during the eyewear purchasing process, help control procurement and warehousing costs, and pioneer innovation in eyewear supply and sales models.

(5) Investment in Beijing Chunyu Tianxia Technology Co., Ltd.

In light of the development prospects and market potential of the mobile healthcare industry, the Company intends to invest RMB 20 million in Beijing Chunyu Tianxia Technology Co., Ltd. (hereinafter referred to as “Chunyu”). Chunyu is a globally leading platform for mobile user consultations and doctor-patient communication, dedicated to leveraging mobile internet technologies to provide users with higher-quality, more affordable, and convenient health services. Its flagship application, the Chunyu Doctor App, meets users’ consultation needs by offering two core services: “self-assessment” and “online consultation.” This has pioneered a new model of medical consultation, positioning Chunyu at the forefront of China’s mobile healthcare sector in terms of user base, user engagement, consultation volume, and market share.

Chunyu possesses profound expertise and extensive experience in mobile health technology and operations. Through this investment, Aier Eye Hospital will establish a close strategic partnership with Chunyu, actively leveraging its established advantages and experience to foster deep collaboration in technology, operations, and patient acquisition, thereby accelerating the company’s expansion in the mobile health sector.

(6) Establish the Chunfeng-Aier Mobile Healthcare Special Fund

To keep pace with emerging technologies, products, and models in the field of ophthalmology, Jishi Interconnect will make an initial capital contribution of RMB 30 million as a limited partner to jointly establish the Chunfeng-Aier Mobile Health Special Fund with Beijing Chunfeng Wanhua Investment Management Co., Ltd., an affiliate of Beijing Chunyu Tianxia Technology Co., Ltd. Leveraging the respective strengths of both parties, the fund will primarily invest in areas such as ophthalmic mobile health, VR/AR, wearable devices, and artificial intelligence. This fund will serve as one of the company’s investment platforms for its strategic layout in the ophthalmic mobile health sector, aiming to further invest in, incubate, and cultivate new application-oriented projects. It will help Aier Eye Hospital reserve more innovative ophthalmology-related projects for future development, thereby creating new drivers for the company’s sustainable growth.